N-Boc-O-tosyl hydroxylamine

CAS No. 105838-14-0

N-Boc-O-tosyl hydroxylamine( —— )

Catalog No. M23263 CAS No. 105838-14-0

N-Boc-O-tosyl hydroxylamine is nitrogen source for the N-amination of aryl and alkyl amines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 38 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-Boc-O-tosyl hydroxylamine
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Boc-O-tosyl hydroxylamine is nitrogen source for the N-amination of aryl and alkyl amines.
  • Description
    N-Boc-O-tosyl hydroxylamine is nitrogen source for the N-amination of aryl and alkyl amines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    105838-14-0
  • Formula Weight
    287.33
  • Molecular Formula
    C12H17NO5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (348.03 mM)
  • SMILES
    O=S(C1=CC=C(C)C=C1)(ONC(OC(C)(C)C)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Thankappan Baburaj, et al. N-Boc-O-Tosyl Hydroxylamine as a Safe and Efficient Nitrogen Source for the N-Amination of Aryl and Alkyl Amines: Electrophylic Amination.
molnova catalog
related products
  • HIV-gp120-41-N-B

    HIV-gp120-41-N-B

  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?

  • IM-54

    IM-54 is a cell-permeable, effective, and selective necrosis inhibitor.